Skip to main content
Figure 8 | Respiratory Research

Figure 8

From: Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways

Figure 8

Effects of anti-α v or anti-β 3 mAb on LPS-induced TNF-α and MIP-2 productions, and on MMP-9 activity. Where indicated, mice were administered anti-αv, anti-β3, or IgG (5 mg/kg, i.p.) once 1 h before LPS treatment and sacrificed 4 h post-LPS. Mice were also administered these mAbs (5 mg/kg, i.p.) once 2 h after LPS and sacrificed 24 h post-LPS. TNF-α(A, D) andMIP-2 (B) productions, and MMP-9 activity (C, E) in BAL fluid. Values represent means ± SEM of 5 mice per group. *Significantly different from saline treated controls, p < 0.05;+significantly different from animals treated with LPS only, p < 0.05.

Back to article page